Table of Content

Chapter 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
Chapter 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
Chapter 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Moderate bargaining power of suppliers
3.3.2. Moderate threat of new entrants
3.3.3. Moderate threat of substitutes
3.3.4. Moderate intensity of rivalry
3.3.5. High bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Surge in demand for advanced diagnostic techniques
3.4.1.2. Rise in incidences of infectious diseases
3.4.1.3. Surge in prevalence of cancer cases
3.4.2. Restraints
3.4.2.1. Lack of awareness regarding advanced diagnostic techniques
3.4.2.2. Lack of skilled personnel for advanced diagnostic testing
3.4.3. Opportunities
3.4.3.1. Rising awareness and demand for point of care testing
Chapter 4: NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY TECHNOLOGY
4.1. Overview
4.1.1. Market size and forecast
4.2. Polymerase Chain Reaction (PCR) Tests
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Isothermal Nucleic Acid Amplification Technology (INAAT) Tests
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.3.4. Isothermal Nucleic Acid Amplification Technology (INAAT) Tests Nucleic Acid Amplification Testing Market by Type
Chapter 5: NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Infectious Disease Testing
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Oncology Testing
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Others
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
Chapter 6: NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY END-USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospital Based Laboratories
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Central, Reference and Standalone Laboratories
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Others
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
Chapter 7: NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by Technology
7.2.3. Market size and forecast, by Application
7.2.4. Market size and forecast, by End-user
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Market size and forecast, by Technology
7.2.5.1.2. Market size and forecast, by Application
7.2.5.1.3. Market size and forecast, by End-user
7.2.5.2. Canada
7.2.5.2.1. Market size and forecast, by Technology
7.2.5.2.2. Market size and forecast, by Application
7.2.5.2.3. Market size and forecast, by End-user
7.2.5.3. Mexico
7.2.5.3.1. Market size and forecast, by Technology
7.2.5.3.2. Market size and forecast, by Application
7.2.5.3.3. Market size and forecast, by End-user
7.3. Europe
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by Technology
7.3.3. Market size and forecast, by Application
7.3.4. Market size and forecast, by End-user
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Market size and forecast, by Technology
7.3.5.1.2. Market size and forecast, by Application
7.3.5.1.3. Market size and forecast, by End-user
7.3.5.2. France
7.3.5.2.1. Market size and forecast, by Technology
7.3.5.2.2. Market size and forecast, by Application
7.3.5.2.3. Market size and forecast, by End-user
7.3.5.3. UK
7.3.5.3.1. Market size and forecast, by Technology
7.3.5.3.2. Market size and forecast, by Application
7.3.5.3.3. Market size and forecast, by End-user
7.3.5.4. Italy
7.3.5.4.1. Market size and forecast, by Technology
7.3.5.4.2. Market size and forecast, by Application
7.3.5.4.3. Market size and forecast, by End-user
7.3.5.5. Spain
7.3.5.5.1. Market size and forecast, by Technology
7.3.5.5.2. Market size and forecast, by Application
7.3.5.5.3. Market size and forecast, by End-user
7.3.5.6. Rest of Europe
7.3.5.6.1. Market size and forecast, by Technology
7.3.5.6.2. Market size and forecast, by Application
7.3.5.6.3. Market size and forecast, by End-user
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by Technology
7.4.3. Market size and forecast, by Application
7.4.4. Market size and forecast, by End-user
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Market size and forecast, by Technology
7.4.5.1.2. Market size and forecast, by Application
7.4.5.1.3. Market size and forecast, by End-user
7.4.5.2. China
7.4.5.2.1. Market size and forecast, by Technology
7.4.5.2.2. Market size and forecast, by Application
7.4.5.2.3. Market size and forecast, by End-user
7.4.5.3. India
7.4.5.3.1. Market size and forecast, by Technology
7.4.5.3.2. Market size and forecast, by Application
7.4.5.3.3. Market size and forecast, by End-user
7.4.5.4. Australia
7.4.5.4.1. Market size and forecast, by Technology
7.4.5.4.2. Market size and forecast, by Application
7.4.5.4.3. Market size and forecast, by End-user
7.4.5.5. South Korea
7.4.5.5.1. Market size and forecast, by Technology
7.4.5.5.2. Market size and forecast, by Application
7.4.5.5.3. Market size and forecast, by End-user
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Market size and forecast, by Technology
7.4.5.6.2. Market size and forecast, by Application
7.4.5.6.3. Market size and forecast, by End-user
7.5. LAMEA
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by Technology
7.5.3. Market size and forecast, by Application
7.5.4. Market size and forecast, by End-user
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Market size and forecast, by Technology
7.5.5.1.2. Market size and forecast, by Application
7.5.5.1.3. Market size and forecast, by End-user
7.5.5.2. Saudi Arabia
7.5.5.2.1. Market size and forecast, by Technology
7.5.5.2.2. Market size and forecast, by Application
7.5.5.2.3. Market size and forecast, by End-user
7.5.5.3. South Africa
7.5.5.3.1. Market size and forecast, by Technology
7.5.5.3.2. Market size and forecast, by Application
7.5.5.3.3. Market size and forecast, by End-user
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Market size and forecast, by Technology
7.5.5.4.2. Market size and forecast, by Application
7.5.5.4.3. Market size and forecast, by End-user
Chapter 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product mapping of top 10 player
8.4. Competitive dashboard
8.5. Competitive heatmap
8.6. Top player positioning, 2022
Chapter 9: COMPANY PROFILES
9.1. Hologic, Inc.
9.1.1. Company overview
9.1.2. Key executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Business performance
9.1.7. Key strategic moves and developments
9.2. New England Biolabs.
9.2.1. Company overview
9.2.2. Key executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.3. Grifols, S.A.
9.3.1. Company overview
9.3.2. Key executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.3.7. Key strategic moves and developments
9.4. BioMerieux SA
9.4.1. Company overview
9.4.2. Key executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Business performance
9.4.7. Key strategic moves and developments
9.5. Illumina Inc.
9.5.1. Company overview
9.5.2. Key executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. Business performance
9.6. Abbott Laboratories
9.6.1. Company overview
9.6.2. Key executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.6.6. Business performance
9.7. Perkin Elmer Inc
9.7.1. Company overview
9.7.2. Key executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.7.6. Business performance
9.7.7. Key strategic moves and developments
9.8. F. Hoffmann-La Roche Ltd.
9.8.1. Company overview
9.8.2. Key executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.8.6. Business performance
9.9. Eiken Chemical Co., Ltd.
9.9.1. Company overview
9.9.2. Key executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.9.6. Business performance
9.10. Siemens AG
9.10.1. Company overview
9.10.2. Key executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
9.10.6. Business performance



List of Figures

LIST OF FIGURES
FIGURE 01. NUCLEIC ACID AMPLIFICATION TESTING MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF NUCLEIC ACID AMPLIFICATION TESTING MARKET,2022-2032
FIGURE 03. TOP IMPACTING FACTORS IN NUCLEIC ACID AMPLIFICATION TESTING MARKET (2022 TO 2032)
FIGURE 04. TOP INVESTMENT POCKETS IN NUCLEIC ACID AMPLIFICATION TESTING MARKET (2023-2032)
FIGURE 05. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 06. MODERATE THREAT OF NEW ENTRANTS
FIGURE 07. MODERATE THREAT OF SUBSTITUTES
FIGURE 08. MODERATE INTENSITY OF RIVALRY
FIGURE 09. HIGH BARGAINING POWER OF BUYERS
FIGURE 10. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11. NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY TECHNOLOGY, 2022 AND 2032(%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF NUCLEIC ACID AMPLIFICATION TESTING MARKET FOR POLYMERASE CHAIN REACTION (PCR) TESTS, BY COUNTRY 2022 AND 2032(%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF NUCLEIC ACID AMPLIFICATION TESTING MARKET FOR ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY (INAAT) TESTS, BY COUNTRY 2022 AND 2032(%)
FIGURE 14. NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY APPLICATION, 2022 AND 2032(%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF NUCLEIC ACID AMPLIFICATION TESTING MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY 2022 AND 2032(%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF NUCLEIC ACID AMPLIFICATION TESTING MARKET FOR ONCOLOGY TESTING, BY COUNTRY 2022 AND 2032(%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF NUCLEIC ACID AMPLIFICATION TESTING MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 18. NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY END-USER, 2022 AND 2032(%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF NUCLEIC ACID AMPLIFICATION TESTING MARKET FOR HOSPITAL BASED LABORATORIES, BY COUNTRY 2022 AND 2032(%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF NUCLEIC ACID AMPLIFICATION TESTING MARKET FOR CENTRAL, REFERENCE AND STANDALONE LABORATORIES, BY COUNTRY 2022 AND 2032(%)
FIGURE 21. COMPARATIVE SHARE ANALYSIS OF NUCLEIC ACID AMPLIFICATION TESTING MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 22. NUCLEIC ACID AMPLIFICATION TESTING MARKET BY REGION, 2022 AND 2032(%)
FIGURE 23. U.S. NUCLEIC ACID AMPLIFICATION TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 24. CANADA NUCLEIC ACID AMPLIFICATION TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 25. MEXICO NUCLEIC ACID AMPLIFICATION TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 26. GERMANY NUCLEIC ACID AMPLIFICATION TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 27. FRANCE NUCLEIC ACID AMPLIFICATION TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 28. UK NUCLEIC ACID AMPLIFICATION TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 29. ITALY NUCLEIC ACID AMPLIFICATION TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 30. SPAIN NUCLEIC ACID AMPLIFICATION TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 31. REST OF EUROPE NUCLEIC ACID AMPLIFICATION TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 32. JAPAN NUCLEIC ACID AMPLIFICATION TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 33. CHINA NUCLEIC ACID AMPLIFICATION TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 34. INDIA NUCLEIC ACID AMPLIFICATION TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 35. AUSTRALIA NUCLEIC ACID AMPLIFICATION TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 36. SOUTH KOREA NUCLEIC ACID AMPLIFICATION TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 37. REST OF ASIA-PACIFIC NUCLEIC ACID AMPLIFICATION TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 38. BRAZIL NUCLEIC ACID AMPLIFICATION TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 39. SAUDI ARABIA NUCLEIC ACID AMPLIFICATION TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 40. SOUTH AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 41. REST OF LAMEA NUCLEIC ACID AMPLIFICATION TESTING MARKET, 2022-2032 ($MILLION)
FIGURE 42. TOP WINNING STRATEGIES, BY YEAR (2020-2023)
FIGURE 43. TOP WINNING STRATEGIES, BY DEVELOPMENT (2020-2023)
FIGURE 44. TOP WINNING STRATEGIES, BY COMPANY (2020-2023)
FIGURE 45. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 46. COMPETITIVE DASHBOARD
FIGURE 47. COMPETITIVE HEATMAP: NUCLEIC ACID AMPLIFICATION TESTING MARKET
FIGURE 48. TOP PLAYER POSITIONING, 2022
FIGURE 49. HOLOGIC, INC.: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 50. HOLOGIC, INC.: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 51. HOLOGIC, INC.: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 52. GRIFOLS, S.A.: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 53. GRIFOLS, S.A.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 54. GRIFOLS, S.A.: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 55. BIOMERIEUX SA: NET SALES, 2020-2022 ($MILLION)
FIGURE 56. BIOMERIEUX SA: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 57. BIOMERIEUX SA: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 58. ILLUMINA INC.: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 59. ILLUMINA INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 60. ILLUMINA INC.: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 61. ABBOTT LABORATORIES: NET SALES, 2020-2022 ($MILLION)
FIGURE 62. ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 63. ABBOTT LABORATORIES: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 64. PERKIN ELMER INC: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 65. PERKIN ELMER INC: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 66. PERKIN ELMER INC: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 67. F. HOFFMANN-LA ROCHE LTD.: SALES REVENUE, 2020-2022 ($MILLION)
FIGURE 68. F. HOFFMANN-LA ROCHE LTD.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 69. SIEMENS AG: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 70. SIEMENS AG: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
FIGURE 71. SIEMENS AG: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 72. SIEMENS AG: REVENUE SHARE BY REGION, 2022 (%)

List of Tables

LIST OF TABLES
TABLE 01. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 02. NUCLEIC ACID AMPLIFICATION TESTING MARKET FOR POLYMERASE CHAIN REACTION (PCR) TESTS, BY REGION, 2022-2032 ($MILLION)
TABLE 03. NUCLEIC ACID AMPLIFICATION TESTING MARKET FOR ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY (INAAT) TESTS, BY REGION, 2022-2032 ($MILLION)
TABLE 04. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY (INAAT) TESTS NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 05. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 06. NUCLEIC ACID AMPLIFICATION TESTING MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION, 2022-2032 ($MILLION)
TABLE 07. NUCLEIC ACID AMPLIFICATION TESTING MARKET FOR ONCOLOGY TESTING, BY REGION, 2022-2032 ($MILLION)
TABLE 08. NUCLEIC ACID AMPLIFICATION TESTING MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 09. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY END-USER, 2022-2032 ($MILLION)
TABLE 10. NUCLEIC ACID AMPLIFICATION TESTING MARKET FOR HOSPITAL BASED LABORATORIES, BY REGION, 2022-2032 ($MILLION)
TABLE 11. NUCLEIC ACID AMPLIFICATION TESTING MARKET FOR CENTRAL, REFERENCE AND STANDALONE LABORATORIES, BY REGION, 2022-2032 ($MILLION)
TABLE 12. NUCLEIC ACID AMPLIFICATION TESTING MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 13. NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 14. NORTH AMERICA NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 15. NORTH AMERICA NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 16. NORTH AMERICA NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY END-USER, 2022-2032 ($MILLION)
TABLE 17. NORTH AMERICA NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 18. U.S. NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 19. U.S. NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 20. U.S. NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY END-USER, 2022-2032 ($MILLION)
TABLE 21. CANADA NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 22. CANADA NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 23. CANADA NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY END-USER, 2022-2032 ($MILLION)
TABLE 24. MEXICO NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 25. MEXICO NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 26. MEXICO NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY END-USER, 2022-2032 ($MILLION)
TABLE 27. EUROPE NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 28. EUROPE NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 29. EUROPE NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY END-USER, 2022-2032 ($MILLION)
TABLE 30. EUROPE NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 31. GERMANY NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 32. GERMANY NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 33. GERMANY NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY END-USER, 2022-2032 ($MILLION)
TABLE 34. FRANCE NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 35. FRANCE NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 36. FRANCE NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY END-USER, 2022-2032 ($MILLION)
TABLE 37. UK NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 38. UK NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 39. UK NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY END-USER, 2022-2032 ($MILLION)
TABLE 40. ITALY NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 41. ITALY NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 42. ITALY NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY END-USER, 2022-2032 ($MILLION)
TABLE 43. SPAIN NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 44. SPAIN NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 45. SPAIN NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY END-USER, 2022-2032 ($MILLION)
TABLE 46. REST OF EUROPE NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 47. REST OF EUROPE NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 48. REST OF EUROPE NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY END-USER, 2022-2032 ($MILLION)
TABLE 49. ASIA-PACIFIC NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 50. ASIA-PACIFIC NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 51. ASIA-PACIFIC NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY END-USER, 2022-2032 ($MILLION)
TABLE 52. ASIA-PACIFIC NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 53. JAPAN NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 54. JAPAN NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 55. JAPAN NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY END-USER, 2022-2032 ($MILLION)
TABLE 56. CHINA NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 57. CHINA NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 58. CHINA NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY END-USER, 2022-2032 ($MILLION)
TABLE 59. INDIA NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 60. INDIA NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 61. INDIA NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY END-USER, 2022-2032 ($MILLION)
TABLE 62. AUSTRALIA NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 63. AUSTRALIA NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 64. AUSTRALIA NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY END-USER, 2022-2032 ($MILLION)
TABLE 65. SOUTH KOREA NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 66. SOUTH KOREA NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 67. SOUTH KOREA NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY END-USER, 2022-2032 ($MILLION)
TABLE 68. REST OF ASIA-PACIFIC NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 69. REST OF ASIA-PACIFIC NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 70. REST OF ASIA-PACIFIC NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY END-USER, 2022-2032 ($MILLION)
TABLE 71. LAMEA NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 72. LAMEA NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 73. LAMEA NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY END-USER, 2022-2032 ($MILLION)
TABLE 74. LAMEA NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 75. BRAZIL NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 76. BRAZIL NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 77. BRAZIL NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY END-USER, 2022-2032 ($MILLION)
TABLE 78. SAUDI ARABIA NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 79. SAUDI ARABIA NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 80. SAUDI ARABIA NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY END-USER, 2022-2032 ($MILLION)
TABLE 81. SOUTH AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 82. SOUTH AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 83. SOUTH AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY END-USER, 2022-2032 ($MILLION)
TABLE 84. REST OF LAMEA NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
TABLE 85. REST OF LAMEA NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 86. REST OF LAMEA NUCLEIC ACID AMPLIFICATION TESTING MARKET, BY END-USER, 2022-2032 ($MILLION)
TABLE 87. HOLOGIC, INC.: KEY EXECUTIVES
TABLE 88. HOLOGIC, INC.: COMPANY SNAPSHOT
TABLE 89. HOLOGIC, INC.: PRODUCT SEGMENTS
TABLE 90. HOLOGIC, INC.: PRODUCT PORTFOLIO
TABLE 91. HOLOGIC, INC.: KEY STRATERGIES
TABLE 92. NEW ENGLAND BIOLABS.: KEY EXECUTIVES
TABLE 93. NEW ENGLAND BIOLABS.: COMPANY SNAPSHOT
TABLE 94. NEW ENGLAND BIOLABS.: PRODUCT SEGMENTS
TABLE 95. NEW ENGLAND BIOLABS.: PRODUCT PORTFOLIO
TABLE 96. GRIFOLS, S.A.: KEY EXECUTIVES
TABLE 97. GRIFOLS, S.A.: COMPANY SNAPSHOT
TABLE 98. GRIFOLS, S.A.: PRODUCT SEGMENTS
TABLE 99. GRIFOLS, S.A.: PRODUCT PORTFOLIO
TABLE 100. GRIFOLS, S.A.: KEY STRATERGIES
TABLE 101. BIOMERIEUX SA: KEY EXECUTIVES
TABLE 102. BIOMERIEUX SA: COMPANY SNAPSHOT
TABLE 103. BIOMERIEUX SA: PRODUCT SEGMENTS
TABLE 104. BIOMERIEUX SA: PRODUCT PORTFOLIO
TABLE 105. BIOMERIEUX SA: KEY STRATERGIES
TABLE 106. ILLUMINA INC.: KEY EXECUTIVES
TABLE 107. ILLUMINA INC.: COMPANY SNAPSHOT
TABLE 108. ILLUMINA INC.: PRODUCT SEGMENTS
TABLE 109. ILLUMINA INC.: PRODUCT PORTFOLIO
TABLE 110. ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 111. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 112. ABBOTT LABORATORIES: PRODUCT SEGMENTS
TABLE 113. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 114. PERKIN ELMER INC: KEY EXECUTIVES
TABLE 115. PERKIN ELMER INC: COMPANY SNAPSHOT
TABLE 116. PERKIN ELMER INC: PRODUCT SEGMENTS
TABLE 117. PERKIN ELMER INC: PRODUCT PORTFOLIO
TABLE 118. PERKIN ELMER INC: KEY STRATERGIES
TABLE 119. F. HOFFMANN-LA ROCHE LTD.: KEY EXECUTIVES
TABLE 120. F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
TABLE 121. F. HOFFMANN-LA ROCHE LTD.: PRODUCT SEGMENTS
TABLE 122. F. HOFFMANN-LA ROCHE LTD.: PRODUCT PORTFOLIO
TABLE 123. EIKEN CHEMICAL CO., LTD.: KEY EXECUTIVES
TABLE 124. EIKEN CHEMICAL CO., LTD.: COMPANY SNAPSHOT
TABLE 125. EIKEN CHEMICAL CO., LTD.: PRODUCT SEGMENTS
TABLE 126. EIKEN CHEMICAL CO., LTD.: PRODUCT PORTFOLIO
TABLE 127. SIEMENS AG: KEY EXECUTIVES
TABLE 128. SIEMENS AG: COMPANY SNAPSHOT
TABLE 129. SIEMENS AG: PRODUCT SEGMENTS
TABLE 130. SIEMENS AG: PRODUCT PORTFOLIO